Spero Therapeutics Inc
F:2HA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Spero Therapeutics Inc
F:2HA
|
US |
|
Mindteck (India) Ltd
BSE:517344
|
IN |
|
Nitori Holdings Co Ltd
TSE:9843
|
JP |
|
C
|
Connected Minerals Ltd
ASX:CML
|
AU |
|
A
|
Applied Materials Inc
SWB:AP2
|
US |
|
L
|
Lam Research Corp
F:LAR0
|
US |
|
Philip Morris International Inc
NYSE:PM
|
US |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
E
|
Eckert & Ziegler SE
XMUN:EUZ
|
DE |
|
Omnicell Inc
NASDAQ:OMCL
|
US |
|
I
|
International Bancshares Corp
F:IB4
|
US |
|
D
|
Daiichi Life Group Inc
F:QHH
|
JP |
|
E
|
Electromagnetic Geoservices ASA
XMUN:E2M
|
NO |
|
ABM Investama Tbk PT
F:0A1
|
ID |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
|
M
|
Morgan Stanley
XMUN:DWD
|
US |
|
C
|
CBRE Group Inc
DUS:RF6
|
US |
|
Deutsche Post AG
XETRA:DHL
|
DE |
|
I
|
Infineon Technologies AG
XHAM:IFX
|
DE |
|
S
|
Stifel Financial Corp
F:2SI
|
US |
|
Sanofi SA
PAR:SAN
|
FR |
|
D
|
DFI Retail Group Holdings Ltd
LSE:DFIB
|
HK |
Bankruptcy Probability
Spero Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Spero Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
60.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Spero Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Spero Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
